 |
Regulations of Connecticut State Agencies (Last Updated: June 14,2023) |
 |
Title20 Professional and Occupational Licensing, Certification |
|
|
SubTitle20-631-1_20-631-3. Collaborative Drug Therapy Management |
| Sec. 20-631-1. Competency requirements |
|
Latest version.
|
|
To qualify for participation in a collaborative drug therapy management agreement, a pharmacist shall be licensed in this state and shall meet at least one of the following qualifications: (1) Bachelor of Science degree in pharmacy with 10 years of clinical experience, or a Pharm.D. degree; (2) Certification by the Board of Pharmaceutical Specialties; (3) Certification by the Commission for Certification in Geriatric Pharmacy; (4) A credential in disease state management from the National Institute for Standards in Pharmacist Credentialing; (5) Pharmacy residency accredited by the American Society of Health-System Pharmacists; or (6) Completion of a disease state management certification program approved by the Accreditation Council for Pharmacy Education. |
|
(Effective January 2, 2013) |
| Sec. 20-631-2. Content of a collaborative drug therapy management agreement |
|
Latest version.
|
|
A collaborative drug therapy management agreement shall include: (1) The types of prescriptive authority decisions the pharmacist may make (e.g., initiation, continuation or modification); (2) Patients who are eligible for treatment; (3) The types of diseases, drugs, or drug categories involved (there are no limitations on disease states or conditions); (4) The procedures, decision criteria, plans, or guidelines the pharmacist is to follow when making therapeutic decisions, particularly when initiating or modifying drug therapy; (5) Required training; (6) A plan for periodic review, feedback and quality assurance; and (7) Procedures for documenting prescribing decisions. |
|
(Effective January 2, 2013) |
| Sec. 20-631-3. Content of patient protocol |
|
Latest version.
|
|
A written protocol for a specific patient established pursuant to a collaborative drug therapy management agreement shall include, but need not be limited to, the following: (1) The specific drug or drugs to be managed by the pharmacist; (2) The terms and conditions under which drug therapy may be implemented, modified or discontinued; (3) The conditions and events that the pharmacist is required to report to the physician; (4) The laboratory tests that may be ordered by the pharmacist; and (5) The drugs that may be administered by the pharmacist. |
|
(Effective January 2, 2013) |